nach oben

Erschienen in:

01.09.2015

Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders

verfasst von: M. Chahua, A. Sánchez-Niubò, M. Torrens, L. Sordo, M. J. Bravo, M. T. Brugal, A. Domingo-Salvany, the ITINERE Project Group

Erschienen in: Quality of Life Research | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Drug addiction and psychiatric disorders are frequently concomitant; however, few studies have investigated the impact of psychiatric disorders other than substance use disorder (SUD) on health-related quality of life (HRQoL) in drug users not in treatment. We studied the association of psychiatric disorders other than SUD with HRQoL in a street-recruited sample of cocaine and/or heroin users.

Methods

It is a cross-sectional study involving 287 young users of cocaine and/or heroin in Barcelona, Spain. HRQoL was assessed with the Nottingham health profile (NHP). Patterns of drug use and mental disorders were assessed using the Spanish version of the psychiatric research interview for substance and mental disorders IV, and degree of dependence through the severity of dependence scale (SDS). The association of mental disorders with HRQoL was assessed through a Tobit regression analysis.

Results

The overall NHP score was 23.9 (SD = 20.5, range 0–91.7). Sixty-one percent of the sample had two or more SUDs; 22 % had at least one non-SUD Axis I disorder (anxiety, mood, psychotic, or eating disorder); and 27.2 % had a borderline personality disorder (BPD) and/or antisocial personality disorder. Variables negatively associated with the global NHP score were psychosis [transformed beta coefficient: 15.23; 95 % confidence interval [CI] 4.48–25.97], BPD (9.55; 95 % CI 2.95–16.15), severity of dependence (8.12; 95 % CI 3.37–12.87), having two or more SUDs (for two or three SUDs: 6.83; 95 % CI 2.08–11.59) (>3 SUDs: 7.70; 95 % CI 1.72–13.68) and the intravenous use of some substance (10.20; 95 % CI 6.00–14.40).

Conclusion

HRQoL among street-recruited illegal substance users was impaired, particularly among those with psychiatric comorbidity, psychosis, and BPD being especially relevant.

European Monitoring Center for Drugs and Drug Addiction. (2012). The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.

Giacomuzzi, S. M., Ertl, M., Kemmler, G., Riemer, Y., & Vigl, A. (2005). Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment. Scientific World Journal, 5, 452–468.PubMedCrossRef

Iraurgi, I., Póo, M., & Márkez, I. (2004). Evaluation of the SF-36 health index applied to methadone maintenance program users. Reference values for the Basque Autonomous Community, Spain. Revista Española de Salud Publica, 78(5), 609–621.CrossRef

Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., & Alonso, J. (1997). Use of the Nottingham health profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92(6), 707–716.PubMedCrossRef

Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95(2), 99–103.PubMed

Nemeth, G. (2006). Health related quality of life outcome instruments. European Spine Journal, 15(Suppl. 1), S44–S51.PubMedCentralPubMedCrossRef

Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., et al. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Diseases, 27(2), 37–48.PubMedCrossRef

Falck, R. S., Wang, J., Carlson, R. G., & Siegal, H. A. (2000). Crack-cocaine use and health status as defined by the SF-36. Addictive Behaviors, 25(4), 579–584.PubMedCrossRef

Puigdollers, E., Domingo-Salvany, A., Brugal, M. T., Torrens, M., Alvaros, J., Castillo, C., et al. (2004). Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender. Substance Use and Misuse, 39(9), 1353–1368.PubMedCrossRef

10.

Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction, 107(4), 709–718.PubMedCentralPubMedCrossRef

11.

Comer, J. S., Blanco, C., Hasin, D. S., Liu, S. M., Grant, B. F., Turner, J. B., & Olfson, M. (2011). Health-related quality of life across the anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions (NESARC). The Journal of Clinical Psychiatry, 72(1), 43–50.PubMedCentralPubMedCrossRef

12.

Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., et al. (2009). The global burden of mental disorders: An update from the WHO world mental health (WMH) surveys. Epidemiologia e Psichiatria Sociale, 18(1), 23–33.PubMedCentralPubMedCrossRef

13.

Perseius, K. I., Andersson, E., Asberg, M., & Samuelsson, M. (2006). Health-related quality of life in women patients with borderline personality disorder. Scandinavian Journal of Caring Sciences, 20(3), 302–307.PubMedCrossRef

14.

Piccinni, A., Catena, M., Del, D. A., Marazziti, D., Monje, C., Schiavi, E., et al. (2007). Health-related quality of life and functioning in remitted bipolar I outpatients. Comprehensive Psychiatry, 48(4), 323–328.PubMedCrossRef

15.

Rubio, J. M., Olfson, M., Villegas, L., Perez-Fuentes, G., Wang, S., & Blanco, C. (2013). Quality of life following remission of mental disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 74(5), e445–e450.PubMedCrossRef

16.

Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.PubMedCrossRef

17.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816.PubMedCrossRef

18.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., & Ruan, W. J. (2005). Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry, 46(1), 1–5.PubMedCrossRef

19.

Hasin, D., Fenton, M. C., Skodol, A., Krueger, R., Keyes, K., Geier, T., et al. (2011). Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Archives of General Psychiatry, 68(11), 1158–1167.PubMedCentralPubMedCrossRef

20.

Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830–842.PubMedCrossRef

21.

Aharonovich, E., Liu, X., Nunes, E., & Hasin, D. S. (2002). Suicide attempts in substance abusers: Effects of major depression in relation to substance use disorders. The American Journal of Psychiatry, 159(9), 1600–1602.PubMedCrossRef

22.

Burns, L., Teesson, M., & O’Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction, 100(6), 787–796.PubMedCrossRef

23.

King, V. L., Kidorf, M. S., Stoller, K. B., & Brooner, R. K. (2000). Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment. Journal of Addictive Diseases, 19(4), 65–83.PubMedCrossRef

24.

Curran, G. M., Sullivan, G., Williams, K., Han, X., Collins, K., Keys, J., & Kotrla, K. J. (2003). Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Annals of Emergency Medicine, 41(5), 659–667.PubMedCrossRef

25.

Lejoyeux, M., Boulenguiez, S., Fichelle, A., McLoughlin, M., Claudon, M., & Ades, J. (2000). Alcohol dependence among patients admitted to psychiatric emergency services. General Hospital Psychiatry, 22(3), 206–212.PubMedCrossRef

26.

Martín-Santos, R., Fonseca, F., Domingo-Salvany, A., Ginés, J. M., Ímaz, M. L., Navinés, R., et al. (2006). Dual diagnosis in the psychiatric emergency room in Spain. The European Journal of Psychiatry, 20, 147–156.CrossRef

27.

Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vázquez, J. M., Martín-Santos, R., & Torrens, M. (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use and Misuse, 43(5), 612–632.PubMedCrossRef

28.

Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use and Misuse, 40(12), 1765–1776.PubMedCrossRef

29.

Carpentier, P. J., Krabbe, P. F., van Gogh, M. T., Knapen, L. J., Buitelaar, J. K., & de Jong, C. A. (2009). Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal on Addictions, 18(6), 470–480.PubMedCrossRef

30.

Domingo-Salvany, A., Brugal, M. T., Barrio, G., Gonzalez-Saiz, F., Bravo, M. J., & de la Fuente, L. (2010). Gender differences in health related quality of life of young heroin users. Health and Quality of Life Outcomes, 8, 145.PubMedCentralPubMedCrossRef

31.

Lozano, O. M., Domingo-Salvany, A., Martinez-Alonso, M., Brugal, M. T., Alonso, J., & de la Fuente, L. (2008). Health-related quality of life in young cocaine users and associated factors. Quality of Life Research, 17(7), 977–985.PubMedCrossRef

32.

Herrero, M. J., Domingo-Salvany, A., Torrens, M., & Brugal, M. T. (2008). Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction, 103(2), 284–293.PubMedCrossRef

33.

Rodríguez-Llera, M. C., Domingo-Salvany, A., Brugal, M. T., Silva, T. C., Sánchez-Niubó, A., & Torrens, M. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84(1), 48–55.PubMedCrossRef

34.

de la Fuente, L., Brugal, M. T., Ballesta, R., Bravo, M. J., Barrio, G., Domingo-Salvany, A., et al. (2005). Cohort study methodology of the ITINERE project on heroin users in three Spanish cities and main characteristics of the participants. Revista Española de Salud Publica, 79(4), 475–491.

35.

Pulido, J., Brugal, M. T., de la Fuente, L., Ballesta, R., Barrio, G., Bravo, M. J., et al. (2009). Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the itinere-cocaine project). Gaceta Sanitaria, 23(3), 200–207.PubMedCrossRef

36.

Heckathorn, D. D. (2011). Snowball versus respondent-driven sampling. Sociological Methodology, 41(1), 355–366.PubMedCentralPubMedCrossRef

37.

Alonso, J., Anto, J. M., & Moreno, C. (1990). Spanish version of the Nottingham health profile: Translation and preliminary validity. American Journal of Public Health, 80(6), 704–708.PubMedCentralPubMedCrossRef

38.

Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., & Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. The American Journal of Psychiatry, 161(7), 1231–1237.PubMedCrossRef

39.

Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. The American Journal of Psychiatry, 163(4), 689–696.PubMedCrossRef

40.

González-Sáiz, F., De las Cuevas, C., Barrio, G., & Domingo-Salvany, A. (2008). Versión española consensuada de la severity of dependence scale (SDS). Medicina Clinica, 131(20), 797.PubMedCrossRef

41.

Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607–614.PubMedCrossRef

42.

Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica, 26(1), 24–36.

43.

Bleda, M. J., & Tobias, A. (2002). Application of tobit regression models in modelling censored epidemiological variables. Gaceta Sanitaria, 16(2), 188–195.CrossRef

44.

Greene, W. (1997). Econometric analysis (3rd ed.). Saddle River, New Jersey: Prentice Hall.

45.

SPSS Inc. & IBM Company. (2010). Statistical program for the social sciences. SPSS.

46.

Core Team, R. (2012). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.

47.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.

48.

González-Sáiz, F., Domingo-Salvany, A., Barrio, G., Sánchez-Niubò, A., Brugal, M. T., de la Fuente, L., & Alonso, J. (2009). Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence. European Addiction Research, 15(2), 87–93.PubMedCrossRef

49.

Alonso, J., Prieto, L., & Anto, J. M. (1994). The Spanish version of the Nottingham health profile: A review of adaptation and instrument characteristics. Quality of Life Research, 3(6), 385–393.PubMedCrossRef

50.

Ware, J. E., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metrics.

51.

Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., et al. (2006). Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. The Journal of Nervous and Mental Disease, 194(3), 164–172.PubMedCrossRef

52.

Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47(8), 853–858.PubMedCrossRef

53.

Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51(4), 273–279.PubMedCrossRef

54.

Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33(5), 1225–1237.PubMedCentralPubMedCrossRef

55.

Gibbie, T. M., Hides, L. M., Cotton, S. M., Lubman, D. I., Aitken, C., & Hellard, M. (2011). The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users. The Medical Journal of Australia, 195(3), S16–S21.PubMed

56.

Soeteman, D. I., Hakkaart-van, R. L., Verheul, R., & Busschbach, J. J. (2008). The economic burden of personality disorders in mental health care. The Journal of Clinical Psychiatry, 69(2), 259–265.PubMedCrossRef

57.

Jackson, H. J., & Burgess, P. M. (2000). Personality disorders in the community: A report from the Australian National Survey of Mental Health and Wellbeing. Social Psychiatry and Psychiatric Epidemiology, 35(12), 531–538.PubMedCrossRef

58.

Masthoff, E. D., Trompenaars, F. J., van Heck, G. L., Michielsen, H. J., Hodiamont, P. P., & De Vries, J. (2007). Predictors of quality of life: A model based study. Quality of Life Research, 16(2), 309–320.PubMedCrossRef

59.

Del Boca, F. K., & Darkes, J. (2003). The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction, 98(Suppl. 2), 1–12.PubMedCrossRef

Titel: Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders
verfasst von: M. Chahua
A. Sánchez-Niubò
M. Torrens
L. Sordo
M. J. Bravo
M. T. Brugal
A. Domingo-Salvany
the ITINERE Project Group
Publikationsdatum: 01.09.2015
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 9/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-015-0943-5

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2015

Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA

Interpreting SF-12 mental component score: an investigation of its convergent validity with CESD-10

Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population

An audit of diabetes-dependent quality of life in patients with type 2 diabetes mellitus in Malaysia

Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients

A longitudinal analysis on pain treatment satisfaction among Chinese patients with chronic pain: predictors and association with medical adherence, disability, and quality of life